A5005744810- Multiple Myeloma Research and Treatments
- Cardiac Structural Anomalies and Repair
- Cancer Treatment and Pharmacology
- Venous Thromboembolism Diagnosis and Management
- Hematopoietic Stem Cell Transplantation
- Chronic Lymphocytic Leukemia Research
- Acute Lymphoblastic Leukemia research
- Cardiovascular Issues in Pregnancy
- Electrolyte and hormonal disorders
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Diagnosis and Treatment of Venous Diseases
- Protein Degradation and Inhibitors
- Phytochemical compounds biological activities
- Lymphoma Diagnosis and Treatment
- Peripheral Neuropathies and Disorders
- Polyomavirus and related diseases
- Pancreatitis Pathology and Treatment
- Aortic aneurysm repair treatments
- Neurological Complications and Syndromes
- Case Reports on Hematomas
- Ultrasound in Clinical Applications
- Neuroscience and Neuropharmacology Research
- Health, psychology, and well-being
- Cardiac Valve Diseases and Treatments
Shifa International Hospital
2021-2024
Shifa Tameer-e-Millat University
2021
Penn State Milton S. Hershey Medical Center
2014-2015
Pennsylvania State University
2015
Mayo Clinic in Arizona
2014
New England College
2013
Mayo Clinic
2013
University at Buffalo, State University of New York
2008-2009
New York Hospital Queens
2009
Wyckoff Heights Medical Center
2009
BACKGROUND: Radiation therapy (RT) is a treatment modality traditionally used in patients with multiple myeloma (MM), but little known regarding the role and effectiveness of RT era novel agents, i.e, immunomodulatory drugs (IMiDs) proteasome inhibitors (PIs). METHODS: We retrospectively reviewed data from 449 consecutive MM seen at our institute 2010-12 to assess indications for as well its effectiveness. Pain response was scored similarly RTOG 0631 numerical rating pain scale (NRPS)....
Immunomodulatory drugs (IMiDs) currently used in the treatment of multiple myeloma, are thalidomide, lenalidomide and pomalidomide. One most common side effects thalidomide is neurotoxicity, predominantly form peripheral neuropathy. We report 6 cases significant central neurotoxicity associated with IMiD therapy. Treatment (1 patient), (4 patients), pomalidomide patient) was various clinical manifestations including reversible coma, amnesia, expressive aphasia, dysarthria. Central should be...
A low molecular weight fraction separated from leukaemic serum and blast cell extract decreased the amplitude of left ventricular contraction oxygen uptake in isolated rabbit heart. The primitive white cells either manufacture or transport cardiodepressant factor, which is present patients with acute myeloid leukaemia. This factor heat stable at 80° C for 30 min.
There is paucity of data on diagnostic criteria Myositis/Muscle chronic Graft-versus-Host disease [cGVHD] due to rarity the condition (<0.7% all Allogeneic- Hematopoietic-Stem-Cell-Transplants [HSCT]. Myalgias are common after HSCT and confounding factors such as drugs (statins, steroids etc.), infections (muscle abscess) tumor infiltration make diagnosis elusive. A algorithm lacking. We retrospectively analyzed allogeneic-HSCTs through Mayo Clinic Database from Jan 1994-July 2013 search for...
1. At a high dilution in Ringer solution (1:200), leukaemic plasma significantly (P &lt; 0.05) decreased the ouabain-sensitive and increased ouabain-insensitive components of sodium efflux from erythrocytes. low (1:10) predominantly total component 0.01). 2. Erythrocytes patients with leukaemia had affinity for factor which inhibited (inhibitory factor). 3. Washings erythrocytes been incubated contained (the anti-ouabain-like 4. These studies show that blood contains two factors have...